Extended schedule, escalated dose temozolomide versus dacarbazine in stage IV melanoma: Final results of a randomised phase III study (EORTC 18032)

2011210 citationsJournal Article

Authors

Good health and well-being

Published in: European Journal of Cancer

Volume 47, Issue 10, pp. 1476-1483

Field-Weighted Citation Impact: 10.58